ArticleLeukemia research2025

Low-dose ropeginterferon alfa-2b and peginterferon alfa-2a have comparable efficacy and tolerability in polycythemia vera.

Neville Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.